Article

COA to Present Virtual Conference Due to Coronavirus

Author(s):

Mary Caffrey

“These are times of unprecedented and unimaginable challenges for our health care system."

The Community Oncology Alliance (COA) will present its annual Community Oncology Conference in a virtual format April 23-24, 2020, to join global efforts to stop the spread of COVID-19 (coronavirus).

“These are times of unprecedented and unimaginable challenges for our health care system,” board members said in a letter today. “We have made the obvious decision to cancel the in-person conference.”

The letter said updates on registering for the virtual meeting would be coming shortly.

Related Videos
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Jessica K. Paulus, ScD, Ontada
Jessica K. Paulus, ScD, Ontada
Michael A. Choti, MD, MBA
Sindhuja Kadambi, MD, MS
Matthew Callister, MD
mily Touloukian, DO, medical oncologist, practice president, and managing partner at Coastal Cancer Center
Neal Shore, MD, FACS, an expert on bladder cancer
Neal Shore, MD, FACS, an expert on bladder cancer
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Related Content
AI models can be useful tools for clinicians, helping assess risk in patients with HCC to inform disease management. | Image credit: ipopba - stock.adobe.com
July 26th 2024

AI Model Precisely Identifies HCC Recurrence Risk Factors

Rose McNulty
Artificial intelligence (AI) models have potential to help clinicians assess risk in patients with hepatocellular carcinoma (HCC) to inform disease management, a new study found.
Managed Care Cast logo
April 25th 2024

Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Colon | Image credit: New Africa - stock.adobe.com
July 24th 2024

Metabolic Dysfunction–Associated Steatotic Liver Disease Linked With CRC

Julia Bonavitacola
Patients diagnoesd with metabolic dysfunction–associated steatotic liver disease may have a higher risk of colorectal cancer (CRC) or colorectal adenoma.
Oncololgy Onward graphic with Dr Bekelman
December 19th 2023

Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman

Maggie L. Shaw
Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Illustration of liver cancer | Image credit: Sebastian Kaulitzki - stock.adobe.com
July 22nd 2024

Response to Immunotherapy Linked With Improved Liver Function in Advanced HCC

Rose McNulty
Although the amount of real-world evidence demonstrating the safety and efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma (HCC) has been growing, data on liver function evolution as a prognostic factor for overall survival are lacking.
STS word cloud | Image Credit: Colored Lights-stock.adobe.com
July 16th 2024

Pembrolizumab Promising in Treating Soft Tissue Sarcoma

Maggie L. Shaw
Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo